CB Insights: ten largest tech companies in US were involved in $2.7B worth of health care equity deals in 2017, up from $277M in 2012
Natasha Singer / New York Times :
Context & Ripple Effects
CB Insights' tally of the ten largest US tech companies taking part in $2.7B of health care equity deals in 2017 — nearly a tenfold jump from $277M five years earlier — is an early marker of tech capital treating health care as a core deployment target rather than an adjacent experiment.
The related coverage traces what came after: healthcare AI startups went on to top every other industry in AI deal activity with $4.3B raised since 2013, and by early 2021 digital health posted a decade-high $7B quarter even as prospective corporate customers began calling some services overpriced and redundant.
First-order effects
- The largest US tech companies shift from selling technology into health care to holding direct equity stakes in it, giving them boardroom-level visibility into clinical and payer workflows they previously reached only as vendors.
- Health care founders gain a new class of deep-pocketed strategic investors alongside traditional VCs, changing who sets terms in early rounds.
Second-order effects
- Venture capital follows the strategics deeper into subsectors — mental health alone drew a record $1.5B in 2020, 5.5x its 2016 level per CB Insights — as big-tech participation signals the category is fundable at scale.
- Buyers respond to the flood of capital with scrutiny: corporate customers of digital health services begin pushing back on pricing and redundancy, pressuring startups funded at peak multiples to prove utilization.
Third-order effects
- If the pattern holds, health care becomes a structurally permanent allocation for tech balance sheets and venture funds alike — visible later in geography too, with Indian health tech drawing $3.7B since 2022, about half the Asia Pacific total.
- Capital saturation pushes differentiation toward proprietary assets: analytics firms holding large patient datasets, such as Clarify Health with data on 300M+ Americans, command billion-dollar-plus valuations while thin-wrapper services face consolidation.
The trend: Tech capital is migrating from peripheral pilots into health care as a primary investment vertical, with each funding wave — strategics, then VCs, then global and data-asset plays — raising the bar for what earns the next round.